Besides a small, but significant decrease in the levels of plasminogen in the LAA samples of AF patients as compared to the FV samples, no significant differences were observed between AF patients and non-AF controls and among sample types concerning FXIII activity, α2-plasmin inhibitor, PAI-1 activity, and plasminogen activity measurements. The gene discussed is PLG; the disease is atrial fibrillation.